hyperalgesia
Post-treatment with S14080 dose-dependently antagonized the hyperalgesia induced by prostaglandin E2, bradykinin, dopamine and by the hyperalgesic cytokines reported to be released by carrageenin (tumour necrosis factor alpha, interleukin-1 and interleukin-8).3.
Post-treatment with S14080 dose-dependently antagonized the <span class="disease" id="7881729-3-60-72">hyperalgesia</span> induced by prostaglandin E2, <span class="gene" id="7881729-3-102-112">bradykinin</span>, dopamine and by the hyperalgesic cytokines reported to be released by carrageenin (tumour necrosis factor alpha, interleukin-1 and interleukin-8).3.